RELATO DE CASO: MUCORMICOSE PULMONAR E RODOCOCOSE EM PACIENTE TRANSPLANTADO RENAL
DOI:
https://doi.org/10.56238/revgeov17n2-052Palavras-chave:
Mucormicose, Infecção por Rhodococcus, Transplante Renal, Infecções Oportunistas, ImunossupressãoResumo
A mucormicose pulmonar é uma infecção fúngica oportunista rara, de evolução rápida e frequentemente letal, especialmente em pacientes imunocomprometidos. O Rhodococcus equi, por sua vez, é um patógeno bacteriano intracelular oportunista de ocorrência incomum em humanos, com maior prevalência em transplantados renais. Relato de um paciente do sexo masculino, 76 anos, transplantado renal há 15 meses, em uso de imunossupressores. O curso clínico foi caracterizado por deterioração progressiva da função renal, insuficiência respiratória, necessidade de suporte intensivo e administração de múltiplos antimicrobianos, incluindo anfotericina B lipossomal, vancomicina e rifampicina. Após investigação extensa com tomografia, fibrobroncoscopia, biópsia e culturas, foi diagnosticado com coinfecção por mucormicose pulmonar e Rhodococcus equi. Apesar das medidas terapêuticas intensivas, o paciente evoluiu a óbito após agravamento clínico. Este relato destaca os desafios diagnósticos e terapêuticos da coinfecção por dois agentes oportunistas raros em paciente transplantado, reforçando a importância do reconhecimento precoce, manejo ágil e intervenção agressiva nesses cenários.
Downloads
Referências
ALVES, Y. et al. “Relato de caso: mucormicose em rim transplantado Case report: mucormycosis in renal allograft”. J Bras Nefrol, v. 24, n. 3, p. 153–159, 2002.
BRASIL. Ministério da Saúde. Boletim epidemiológico “Murcomicose” 2024. Brasília:/https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/m/mucormicose. Acesso em: 08 de fevereiro de 2025.
COHEN, N. D. et al. “Association of pneumonia with concentrations of virulent Rhodococcus equi in fecal swabs of foals before and after intrabronchial infection with virulent R. equi”. Journal of Veterinary Internal Medicine, Hoboken, v. 36, n. 3, p. 1139-1145, 2022. DOI: 10.1111/jvim.16409.
DANDU, H.; SHARMA, V.; SINGH, R.; GUPTA, A.; KHANDELWAL, P.; MEHROTRA, R.; & KUMAR, A. (2024). “Utility of Itraconazole in Combination with Liposomal Amphotericin B in Rhizopus oryzae Associated Mucormycosis–An Exploratory Study”. Mycopathologia, 189(4), 54.
DRAVID, A.; SAOJI, R.; BHALERAO, M.; GAIKWAD, P.; DOSHI, R.; & JOG, S. (2022). “Epidemiology, clinical presentation and management of COVID‐19 associated mucormycosis: A single centre experience from Pune.” Western India. Mycoses, 65(5), 526-540.
ESHRAGHI, B.; RAHIMI, M.; AMINI, A.; SHIRAZI, M. T.; NASIRI, M.; KARIMI, Z.; & SADEGHI, A. (2024). “Risk Factors of COVID-19 associated mucormycosis in Iranian patients: a multicenter study”. BMC Infectious Diseases, 24(1), 852.
FARIAS, L. A. B. G., DAMASCENO, L. S., BANDEIRA, S. P., BARRETO, F. K. DE A., LEITÃO, T. DO M. J. S., & CAVALCANTI, L. P. DE G. (2021). “COVID-19 associated Mucormycosis (CAM): Should Brazil be on alert?” Revista Da Sociedade Brasileira de Medicina Tropical, 54, e0410. https://doi.org/10.1590/0037-8682-0410 2021
GANDHI, A.; KUMAR, A.; GUPTA, N.; SHARMA, P.; YADAV, H.; & SHARMA, R. (2023). “Battling the emerging epidemic of rhino-orbital-cerebral mucormycosis (ROCM) in COVID-19 pandemic: an interventional study”. International Ophthalmology, 43(5), 1571–1580.
GONZÁLEZ-RONCERO FM, GENTIL MA, RODRIGUEZ-ALGARRA G, PEREIRA P, CISNEROS JM, CASTILLA JJ, ROCHA JL, MATEOS J. “Medical management of pneumonia caused by Rhodococcus equi in a renal transplant recipient. Am J Kidney Dis. 2002” Feb;39(2):E7. doi: 10.1053/ajkd.2002.30574. PMID: 11840398.
GURTLER, V. et al. Can whole genome analysis refine the taxonomy of the genus Rhodococcus? FEMS Microbiology Reviews, v.28, n.3, p.377-403, 2004.
HASE, A. et al. “Successful Management of Pulmonary Mucormycosis Presenting as Round Pneumonia by Lung Resection in a Kidney Transplant Recipient”. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, v. 34, n. Suppl 1, p. S226–S229, jan. 2023.
HUSSAIN, M. K.; KHAN, M. S.; AHMAD, I.; SHARIQ, A.; SINGH, M.; NAEEM, A.; & KHAN, R. A. (2023). “Mucormycosis: A hidden mystery of fungal infection, possible diagnosis, treatment and development of new therapeutic agents. European” Journal of Medicinal Chemistry, 246, 115010.
JAIN, V.; SHARMA, A.; KAPOOR, S.; GUPTA, P.; KUMAR, A.; & AGRAWAL, R. (2023). Hit or Miss: “The dilemma of specimen selection for microbiological diagnosis of rhino-orbital-cerebral-COVID-associated mucormycosis (ROCM-CAM). Infectious Disorders-Drug Targets” (Formerly Current Drug Targets-Infectious Disorders), 23(1), 62-69.
JEONG, W., KEIGHLEY, C., WOLFE, R., LEE, W. L., SLAVIN, M. A., KONG, D. C. M., & CHEN, S. C.-A. (2019). “The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports”. Clinical Microbiology and Infection, 25(1), 26–34. https://doi.org/10.1016/j.cmi.2018.07.011
KESHRI, A.; KUMAR, A.; KUMAR, S.; PANDEY, R.; & SINGH, P. (2023). “Is mucormycosis the end? A comprehensive management of orbit in COVID-associated rhino-orbital–cerebral mucormycosis: preserving the salvageable”. European Archives of Oto-Rhino-Laryngology, 280(2), 819-827.
KHARE, P.; CHAURASIA, Y.; & BHATNAGAR, S. (2022). “Exploring the globe salvaging treatment options in patients of COVID-19-associated mucormycosis with orbital involvement”. Indian Journal of Ophthalmology, 70(10), 3638-3642.
KIRKAN, Ş. et al. “Detection of Rhodococcus equi by PCR from foals and determination of antimicrobial susceptibility”. Turkish Journal of Veterinary and Animal Sciences, v. 45, n. 3, p. 396-403, 2021. DOI: 10.3906/vet-2011-109, 2025.
KULKARNI, R.; MISRA, U. K.; MESHRAM, C.; KOCHAR, D.; MODI, M.; VISHNU, VENUGOPALAN, Y.; GARG, R. K.; & SURYA, N. (2022). “Epidemic of mucormycosis in COVID-19 pandemic: a position paper”. Annals of Indian Academy of Neurology, 25(1), 7–10.
LIANG, G.-F. et al. “Pleural empyema with endobronchial mass due to Rhodococcus equi infection after renal transplantation: A case report and review of literature”. World Journal of Clinical Cases, v. 12, n. 1, p. 224–231, 2 jan. 2024.
LIANG, M. et al. “Epidemiology, pathogenesis, clinical characteristics, and treatment of mucormycosis: a review”. Annals of Medicine, v. 56, n. 1, 2 set. 2024.
MACKEN, E. et al. “Rhodococcus equi Sepsis in a Renal Transplant Recipient. Transplantation Direct, v. 1, n. 3, p. 1–6, abr. 2015.
MACKENZIE, C. “An update on Rhodococcus equi pneumonia in foals”. Uk-Vet Equine, v. 7, n. 1, p. 6-9, 2023.
MEDEIROS, P. R. et al. “Survey on sanitary practices and knowledge about infectious diseases among equine owners in the State of Rio Grande do Norte, Brazil. Brazilian” Journal of Veterinary Medicine, v. 45, p. 1-12, 2023.
MEGALE, R. S.; LINO, E. Z. B.; RIBEIRO, A. “Infecção por Rhodococcus equi em potra: relato de caso”. Pubvet, v. 17, n. 9, p. 1-6, 18 set. 2024.
PRESCOTT, J. “Rhodococcus equi: an Animal and Human Pathogen”. CLINICAL MICROBIOLOGY REVIEWS, v. 4, n. 1, p. 20–34, 1991.
RAKOWSKA, A. et al. “Investigation of the relationship between pulmonary lesions based on lung ultrasound and respiratory clinical signs in foals with suspected pulmonary rhodococcosis”. Scientific Reports, v. 13, n. 1, p. 19401, 2023. DOI: 10.1038/s41598-023-46833-2.
RIET-CORREA, F. et al. “Doenças de equinos e ruminantes”. 4. ed. São Paulo: Livraria Varela, 2022. v. 2, p. 306–314.
SEVERO, L. C. et al. Infecção pulmonar por “Rhodococcus equi”: relato dos dois primeiros casos brasileiros. Jornal de Pneumologia, v. 27, n. 3, p. 158–162, 1 maio 2001.
SONG, Y. et al. Mucormycosis in renal transplant recipients: review of 174 reported cases. BMC Infectious Diseases, v. 17, p. 283, 18 abr. 2017.
VAROTTI, G. et al. “Unusual Extrapulmonary Rhodococcus Equi Infection in a Kidney Transplant Patient. Experimental and clinical transplantation”. official journal of the Middle East Society for Organ Transplantation, v. 14, n. 6, p. 676–678, dez. 2016.
VERGIDIS, P. et al. RhodococcusInfection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients1”. Emerging Infectious Diseases, v. 23, n. 3, p. 510–512, mar. 2017.
